{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T11:24:29Z","timestamp":1790162669663,"version":"4.1.0"},"reference-count":44,"publisher":"Bioscientifica","issue":"12","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["ec.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,12]]},"abstract":"<jats:p>Only few descriptions of intraoperative carcinoid syndrome (ioCS) have been reported. The primary objective of this study was to describe ioCS. A second aim was to identify risk factors of ioCS. We retrospectively analysed patients operated for small-bowel neuroendocrine tumour in our institution between 2007 and 2015, and receiving our preventive local regimen of octreotide continuous administration. ioCS was defined as highly probable in case of rapid (&lt;5\u2009min) arterial blood pressure changes \u226540%, not explained by surgical\/anaesthetic management and regressive \u226520% after octreotide bolus injection. Probable cases were ioCS which did not meet all criteria of highly-probable ioCS. Suspected ioCS were detected on the anaesthesia record by an injection of octreotide due to a manifestation which did not meet the criteria for highly-probable or probable ioCS. A total of 81 patients (liver metastases: 59, prior carcinoid syndrome: 49, carcinoid heart disease: 7) were included; 139 ioCS occurred in 45 patients: 45 highly probable, 67 probable and 27 suspected. ioCs was hypertensive (91%) and\/or hypotensive (29%). There was no factor, including the use of vasopressors, significantly associated with the occurrence of an ioCS. All surgeries were completed and one patient died from cardiac failure 4 days after surgery. After preoperative octreotide continuous infusion, ioCS were mainly hypertensive. No ioCS risk factors, including vasopressor use, were identified. No intraoperative carcinoid crisis occurred, suggesting the clinical relevance of a standardized octreotide prophylaxis protocol.<\/jats:p>","DOI":"10.1530\/ec-18-0324","type":"journal-article","created":{"date-parts":[[2018,10,4]],"date-time":"2018-10-04T09:00:14Z","timestamp":1538643614000},"page":"1245-1250","update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-10","source":"Crossref","is-referenced-by-count":18,"title":["Intraoperative carcinoid syndrome during small-bowel neuroendocrine tumour surgery"],"prefix":"10.1530","volume":"7","author":[{"given":"Myrtille","family":"Fouch\u00e9","sequence":"first","affiliation":[{"name":"1Department of Anaesthesiology and Critical Care Medicine, Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Bouffard","sequence":"additional","affiliation":[{"name":"1Department of Anaesthesiology and Critical Care Medicine, Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary-Charlotte","family":"Le Goff","sequence":"additional","affiliation":[{"name":"1Department of Anaesthesiology and Critical Care Medicine, Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanne","family":"Prothet","sequence":"additional","affiliation":[{"name":"1Department of Anaesthesiology and Critical Care Medicine, Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Malavieille","sequence":"additional","affiliation":[{"name":"1Department of Anaesthesiology and Critical Care Medicine, Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Sagnard","sequence":"additional","affiliation":[{"name":"1Department of Anaesthesiology and Critical Care Medicine, Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Christin","sequence":"additional","affiliation":[{"name":"1Department of Anaesthesiology and Critical Care Medicine, Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davy","family":"Hayi-Slayman","sequence":"additional","affiliation":[{"name":"1Department of Anaesthesiology and Critical Care Medicine, Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Pasquer","sequence":"additional","affiliation":[{"name":"2Department of Visceral Surgery, Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Poncet","sequence":"additional","affiliation":[{"name":"2Department of Visceral Surgery, Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Walter","sequence":"additional","affiliation":[{"name":"3Department of Hepatogastroenterology and Oncology, Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Rimmel\u00e9","sequence":"additional","affiliation":[{"name":"1Department of Anaesthesiology and Critical Care Medicine, Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, France"},{"name":"4EA 7426 Hospices Civils de Lyon-University Claude Bernard Lyon 1-Biom\u00e9rieux \u2018Pathophysiology of Injury-Induced Immunosuppression\u2019 Pi3, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","reference":[{"key":"ref11","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s00392-006-0463-y","article-title":"Atrial fibrillation in carcinoid heart disease: the role of serotonin. A review of the literature","volume":"96","year":"2007","journal-title":"Clinical Research in Cardiology"},{"key":"ref421","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.surg.2015.05.036","article-title":"Continuous infusion of octreotide combined with perioperative octreotide bolus does not prevent intraoperative carcinoid crisis","volume":"159","year":"2016","journal-title":"Surgery"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jclinane.2010.12.009","article-title":"Carcinoid syndrome and perioperative anesthetic considerations","volume":"23","year":"2011","journal-title":"Journal of Clinical Anesthesia"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"bcr2014207732","DOI":"10.1136\/bcr-2014-207732","article-title":"Carcinoid heart disease: correlation of echocardiographic and histopathological findings","volume":"2014","year":"2014","journal-title":"BMJ Case Reports"},{"key":"ref381","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S1470-2045(07)70410-2","article-title":"Gastroenteropancreatic neuroendocrine tumours","volume":"9","year":"2008","journal-title":"Lancet Oncology"},{"key":"ref131","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1056\/NEJMoa1316158","article-title":"Lanreotide in metastatic enteropancreatic neuroendocrine tumors","volume":"371","year":"2014","journal-title":"New England Journal of Medicine"},{"key":"ref01","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0952-8180(01)00353-1","article-title":"Carcinoid heart disease: a case report and literature review","volume":"14","year":"2002","journal-title":"Journal of Clinical Anesthesia"},{"key":"ref211","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/01.anes.0000270724.40897.8e","article-title":"Incidence of intraoperative hypotension as a function of the chosen definition: literature definitions applied to a retrospective cohort using automated data collection","volume":"107","year":"2007","journal-title":"Anesthesiology"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1093\/bja\/aen237","article-title":"Management of patients undergoing multivalvular surgery for carcinoid heart disease: the role of the anaesthetist","volume":"101","year":"2008","journal-title":"British Journal of Anaesthesia"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s00268-016-3432-2","article-title":"Surgical treatment of NEN of small bowel: a retrospective analysis","volume":"40","year":"2016","journal-title":"World Journal of Surgery"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ijcard.2008.02.019","article-title":"Carcinoid heart disease","volume":"129","year":"2008","journal-title":"International Journal of Cardiology"},{"key":"ref271","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ijcard.2008.02.019","article-title":"Carcinoid heart disease","volume":"129","year":"2008","journal-title":"International Journal of Cardiology"},{"key":"ref331","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1097\/MPA.0b013e3181ebb2a5","article-title":"The NANETS consensus guideline for the diagnosis and management of neuroendocrine tumors: well-differentiated neuroendocrine tumors of the Jejunum, Ileum, Appendix, and Cecum","volume":"39","year":"2010","journal-title":"Pancreas"},{"key":"ref391","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1093\/bja\/87.3.447","article-title":"Perianaesthetic risks and outcomes of abdominal surgery for metastatic carcinoid tumours","volume":"87","year":"2001","journal-title":"British Journal of Anaesthesia"},{"key":"ref151","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1161\/01.CIR.87.4.1188","article-title":"Carcinoid heart disease. Clinical and echocardiographic spectrum in 74 patients","volume":"87","year":"1993","journal-title":"Circulation"},{"key":"ref241","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000111034","article-title":"Consensus guidelines for the management of patients with digestive neuroendocrine tumors-well-differentiated jejunal-ileal tumor\/carcinoma","volume":"87","year":"2008","journal-title":"Neuroendocrinology"},{"key":"ref81","first-page":"742","article-title":"Surgical management of small bowel neuroendocrine tumors : specific requirements and their impact on staging and prognosis of Supplement https org","author":"BohasCPoncetG","journal-title":"Annals Surgical Oncology"},{"key":"ref141","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1159\/000443170","article-title":"ENETS consensus guidelines update for neuroendocrine neoplasm of the jejunum and ileum","volume":"103","year":"2016","journal-title":"Neuroendocrinology"},{"key":"ref291","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.ahj.2014.03.018","article-title":"Carcinoid heart disease: current understanding and future directions","volume":"167","year":"2014","journal-title":"American Heart Journal"},{"key":"ref431","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/01.anes.0000270724.40897.8e","article-title":"Incidence of intraoperative hypotension as a function of the chosen definition: literature definitions applied to a retrospective cohort using automated data collection","volume":"107","year":"2007","journal-title":"Anesthesiology"},{"key":"ref261","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1093\/bja\/aen237","article-title":"Management of patients undergoing multivalvular surgery for carcinoid heart disease: the role of the anaesthetist","volume":"101","year":"2008","journal-title":"British Journal of Anaesthesia"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000111034","article-title":"Consensus guidelines for the management of patients with digestive neuroendocrine tumors-well-differentiated jejunal-ileal tumor\/carcinoma","volume":"87","year":"2008","journal-title":"Neuroendocrinology"},{"key":"ref251","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jclinane.2010.12.009","article-title":"Carcinoid syndrome and perioperative anesthetic considerations","volume":"23","year":"2011","journal-title":"Journal of Clinical Anesthesia"},{"key":"ref281","doi-asserted-by":"crossref","first-page":"bcr2014207732","DOI":"10.1136\/bcr-2014-207732","article-title":"Carcinoid heart disease: correlation of echocardiographic and histopathological findings","volume":"2014","year":"2014","journal-title":"BMJ Case Reports"},{"key":"ref201","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.surg.2015.05.036","article-title":"Continuous infusion of octreotide combined with perioperative octreotide bolus does not prevent intraoperative carcinoid crisis","volume":"159","year":"2016","journal-title":"Surgery"},{"key":"ref181","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/jso.23323","article-title":"Octreotide LAR and bolus octreotide are insufficient for preventing intraoperative complications in carcinoid patients","volume":"107","year":"2013","journal-title":"Journal of Surgical Oncology"},{"key":"ref371","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1161\/01.CIR.87.4.1188","article-title":"Carcinoid heart disease. Clinical and echocardiographic spectrum in 74 patients","volume":"87","year":"1993","journal-title":"Circulation"},{"key":"ref311","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s00268-016-3432-2","article-title":"Surgical treatment of NEN of small bowel: a retrospective analysis","volume":"40","year":"2016","journal-title":"World Journal of Surgery"},{"key":"ref321","doi-asserted-by":"crossref","first-page":"4656","DOI":"10.1200\/JCO.2009.22.8510","article-title":"Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group","volume":"27","year":"2009","journal-title":"Journal of Clinical Oncology"},{"key":"ref361","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1159\/000443170","article-title":"ENETS consensus guidelines update for neuroendocrine neoplasm of the jejunum and ileum","volume":"103","year":"2016","journal-title":"Neuroendocrinology"},{"key":"ref301","first-page":"742","article-title":"Surgical management of small bowel neuroendocrine tumors : specific requirements and their impact on staging and prognosis of Supplement https org","author":"BohasCPoncetG","journal-title":"Annals Surgical Oncology"},{"key":"ref121","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/gutjnl-2011-300831","article-title":"Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs)","volume":"61","year":"2012","journal-title":"Gut"},{"key":"ref411","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1007\/s12630-012-9879-1","article-title":"Mega-dose intravenous octreotide for the treatment of carcinoid crisis: a systematic review","volume":"60","year":"2013","journal-title":"Canadian Journal of Anaesthesia"},{"key":"ref221","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0952-8180(01)00353-1","article-title":"Carcinoid heart disease: a case report and literature review","volume":"14","year":"2002","journal-title":"Journal of Clinical Anesthesia"},{"key":"ref111","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1097\/MPA.0b013e3181ebb2a5","article-title":"The NANETS consensus guideline for the diagnosis and management of neuroendocrine tumors: well-differentiated neuroendocrine tumors of the Jejunum, Ileum, Appendix, and Cecum","volume":"39","year":"2010","journal-title":"Pancreas"},{"key":"ref171","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1093\/bja\/87.3.447","article-title":"Perianaesthetic risks and outcomes of abdominal surgery for metastatic carcinoid tumours","volume":"87","year":"2001","journal-title":"British Journal of Anaesthesia"},{"key":"ref351","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1056\/NEJMoa1316158","article-title":"Lanreotide in metastatic enteropancreatic neuroendocrine tumors","volume":"371","year":"2014","journal-title":"New England Journal of Medicine"},{"key":"ref191","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1007\/s12630-012-9879-1","article-title":"Mega-dose intravenous octreotide for the treatment of carcinoid crisis: a systematic review","volume":"60","year":"2013","journal-title":"Canadian Journal of Anaesthesia"},{"key":"ref341","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/gutjnl-2011-300831","article-title":"Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs)","volume":"61","year":"2012","journal-title":"Gut"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.ahj.2014.03.018","article-title":"Carcinoid heart disease: current understanding and future directions","volume":"167","year":"2014","journal-title":"American Heart Journal"},{"key":"ref101","doi-asserted-by":"crossref","first-page":"4656","DOI":"10.1200\/JCO.2009.22.8510","article-title":"Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group","volume":"27","year":"2009","journal-title":"Journal of Clinical Oncology"},{"key":"ref161","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S1470-2045(07)70410-2","article-title":"Gastroenteropancreatic neuroendocrine tumours","volume":"9","year":"2008","journal-title":"Lancet Oncology"},{"key":"ref401","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/jso.23323","article-title":"Octreotide LAR and bolus octreotide are insufficient for preventing intraoperative complications in carcinoid patients","volume":"107","year":"2013","journal-title":"Journal of Surgical Oncology"},{"key":"ref231","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s00392-006-0463-y","article-title":"Atrial fibrillation in carcinoid heart disease: the role of serotonin. A review of the literature","volume":"96","year":"2007","journal-title":"Clinical Research in Cardiology"}],"container-title":["Endocrine Connections"],"original-title":[],"link":[{"URL":"https:\/\/ec.bioscientifica.com\/view\/journals\/ec\/7\/12\/EC-18-0324.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ec.bioscientifica.com\/downloadpdf\/journals\/ec\/7\/12\/EC-18-0324.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T13:43:04Z","timestamp":1784554984000},"score":1,"resource":{"primary":{"URL":"http:\/\/journals.bioscientifica.com\/ec\/article\/7\/12\/1245-1250\/394"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":44,"journal-issue":{"issue":"12"},"URL":"https:\/\/doi.org\/10.1530\/ec-18-0324","relation":{},"ISSN":["2049-3614"],"issn-type":[{"value":"2049-3614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12]]}}}